The Effect of COVID-19 On Treatment Outcomes in Non-Small Cell Lung Cancer Patients: A Propensity Score Matched Analysis

被引：0

作者：

Aung, W. Y. ^{[1
]}

Sood, A. ^{[2
]}

Hou, L. ^{[2
]}

Elengickal, J. ^{[3
]}

Peketi, S. H. ^{[4
]}

Locke, M. ^{[1
]}

Zhou, X. ^{[2
]}

Sangari, A. ^{[5
]}

Seetharamu, N. ^{[1
]}

机构：

[1] RJ Zuckerberg Canc Ctr, New Hyde Pk, NY USA

[2] Northshore Univ Hosp Northwell Hlth, Manhasset, NY USA

[3] Prisma Hlth Midlands, Columbia, SC USA

[4] Nassau Univ Med Ctr, East Meadow, NY USA

[5] SUNY Stony Brook, Stony Brook, NY USA

来源：

关键词：

COVID-19; NSCLC; Immune checkpoint inhibitor;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P4.11E.19

引用

页码：S403 / S404

页数：2